Kay Shigemori joined the Department of Oncology as a DPhil student from 2018. Prior to arriving at Oxford, she did her Bachelors degree in Biology at Colby College in Maine, USA. After completing her undergraduate studies, she worked as a research assistant in the Weinstock laboratory at the Dana-Farber Cancer Institute (DFCI) in Boston. During her time at DFCI, she contributed to several translational research projects and led the patient-derived leukemia and lymphoma xenografts effort.
Kay is currently studying the role of the immune microenvironment in lung cancer development. Her study looks at the involvement of innate immunity, such as the virally-induced cGAS-STING pathway in the process of lung tumour development.
She is a recipient of the National Cancer Research Institute Award in 2020.
Radiation and DMXAA limit tumour development in a urethane-induced lung cancer model through inflammatory response.
Jiang Y. et al, (2021), Br J Cancer, 124, 1809 - 1819
Yoshida N. et al, (2020), Blood, 135, 1467 - 1471
Beheshti A. et al, (2019), Scientific Reports, 9
Yoshida N. et al, (2019), BLOOD, 134
Lee D. et al, (2019), FASEB BioAdvances, 1, 511 - 520